에 대한 최신 뉴스 Donaldson (NYSE:DCI) 주식

Donaldson

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.

Analysts

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

도날드슨 컴퍼니(NYSE:DCI)은 12월 3일 화요일 개장 전 1분기 실적을 발표할 예정이다. 애널리스트들은 도날드슨이 분기당 주당 82센트의 순이익을 보고할 것으로 예상하고 있다. 이는 1년 전 주당 75센트에서 상승한 수치이다. 미네소타주 블루밍턴에 본사를 둔 이 회사는 분기별 매출이 8억 9,349만 달러로 전년 동기 8억 4,630만 달러에 비해 증가할 것으로 예상하고 있다.

도날드슨, 1분기 실적 준비: 월스트리트의 가장 정확한 분석가들의 최근 예측 변화는?

Donaldson Co Inc

DCI ADVISORS LTD by DCI ADVISORS LTD

<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.isolerebio.com%2F&amp;esheet=54243241&amp;newsitemid=20250424252130&amp;lan=en-US&amp;anchor=Isolere+Bio+by+Donaldson&amp;index=1&amp;md5=3db5e8d0847384827cd19b0b45763e74">Isolere Bio by Donaldson</a>, an innovative bioprocessing technology provider, proudly announces the availability of its manufacturing-grade IsoTag&#x2122; AAV reagent for the purification of Adeno-associated Virus (AAV) vectors. As indicated <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.isolerebio.com%2Farticles%2Fresearch-grade-isotag-aav-reagent-announcement&amp;esheet=54243241&amp;newsitemid=20250424252130&amp;lan=en-US&amp;anchor=during+the+launch+of+the+research-grade+reagent&amp;index=2&amp;md5=2fe070e9555e7100349c16f41a752593">during the launch of the research-grade reagent</a> in October 2024, this final advancement in product grade now includes production with validated processes and the availability of a full suite of documentation, including a Regulatory Support File (RSF), validation guide and full design history upon customer request. Additionally, the U.S. Food and Drug Administration (FDA) has acknowledged its receipt of the recently submitted Drug Master File (DMF) for the IsoTag&#x2122; AAV reagent, which will support and streamline clinical manufacturing using the reagent.
 &nbsp;

Isolere Bio By Donaldson Announces Availability Of Manufacturing-grade IsoTag AAV Reagent For Purification Of AAV Vectors

In the current session, Donaldson Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) is trading at $61.70, after a 1.66% decrease. Over the past month, the stock decreased by 9.65%, and in the past year, by 14.83%. With performance like this, long-term shareholders are more likely to start looking into the company's price-to-earnings ratio. 

<img src="https://www.benzinga.com/files/images/story/2025/1745272822_0.png" alt="Past Year Chart" />

<h3>Comparing Donaldson P/E Against Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 25.15 in the Machinery industry, Donaldson Inc. has a lower P/E ratio of 18.35. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1745272822_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Price Over Earnings Overview: Donaldson

Stifel analyst Nathan Jones maintains Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) with a Hold and lowers the price target from $70 to $63.

Stifel Maintains Hold on Donaldson, Lowers Price Target to $63

In a new SEC filing on April 11, it was revealed that Owens, Board Member at Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>), executed a significant exercise of company stock options.
What Happened: Owens, Board Member at Donaldson, exercised stock options for 18,700 shares of DCI stock. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000029644/000002964425000045//Archives/edgar/data/29644/000002964425000045/0000029644-25-000045-index.htm">U.S. Securities and Exchange Commission</a> on Friday. The exercise price of the options was $28.43 per share.
As of Friday morning, Donaldson shares are down by 0.0%, with a current price of $62.15. This implies that Owens's 18,700 shares have a value of $630,564.
<h3>Delving into Donaldson's Background</h3>
Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.
<h3>Breaking Down Donaldson's Financial Performance</h3>
Revenue Challenges: Donaldson's revenue growth over 3 months faced difficulties. As of 31 January, 2025, the company experienced a decline of approximately -0.76%. This indicates a decrease in top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Holistic Profitability Examination:
<ul>
<li>
Gross Margin: With a low gross margin of 35.16%, the company exhibits below-average profitability, signaling potential struggles in cost efficiency compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Donaldson exhibits below-average bottom-line performance with a current EPS of 0.8.
</li>
</ul>
Debt Management: Donaldson's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.37.
Insights into Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: Donaldson's P/E ratio of 18.17 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 2.09 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 11.83, Donaldson presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
In the complex landscape of investment decisions, investors should approach insider transactions as part of a comprehensive analysis, considering various elements.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Breaking Down the Significance of Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000029644">Check Out The Full List Of Donaldson's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Major Exercise Alert: James Owens Exercises Options Worth $630K At Donaldson

Ginkgo Bioworks and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems

Contracts

Ginkgo Bioworks Works With Partners On ARPA-H Project To Stabilize Pharmaceutical Supply Chains

WIIM

AGCO

ALSN

ASTE

ATMU

BLBD

CVGI

EPAC

ESAB

FELE

FSTR

GTES

GTLS

HLIO

LECO

LXFR

MIDD

OTIS

PCAR

PDYN

PRLB

RAIL

SPXC

TWIN

UGRO

WPRT

Shares of machinery companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Donaldson Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) shares are trading higher after the company&nbsp;reported&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b44000829/donaldson-reports-second-quarter-fiscal-year-2025-sales-and-earnings" rel="noreferrer noopener">second-quarter results</a>.
Sales fell 0.8% year over year to&nbsp;$870.0 million,&nbsp;missing the consensus of&nbsp;$908.33 million, due to a 170 basis point negative impact from currency translation.
By Segment, Mobile Solutions sales declined 0.5% Y/Y, with Aftermarket sales climbing&nbsp;4.0% Y/Y, aided by strong demand in the OEM channel.
Industrial Filtration Solutions sales fell by 7.5% due to slower capital expenditure investments and the timing of Power Generation projects, while Aerospace and Defense sales rose 18.7% Y/Y, led by strong demand in the Defense sector.
Life Sciences segment sales increased&nbsp;9.2%, led by higher volume growth in Disk Drive.
Gross margin remained flat Y/Y at&nbsp;35.2% in the quarter. Adjusted EPS of&nbsp;83 cents <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">missed the consensus of&nbsp;85 cents</a>.
Year-to-date, Donaldson paid&nbsp;$64.6 million in dividends and repurchased shares worth&nbsp;$81.4 million.
Last month, the Board of Directors declared a cash dividend per share of 27.0 cents, payable on February 28, to&nbsp;shareholders&nbsp;of record as <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b43321809/donaldson-company-declares-quarterly-cash-dividend" rel="noreferrer noopener">on February 13, 2025</a>.
Tod Carpenter, chairman, president, and chief executive officer, said, &#8220;We generated sales growth in Aftermarket, Aerospace and Defense, and Life Sciences, while also diligently managing costs and further optimizing operating expenses.&#8221;
&#8221;Our diversified portfolio of businesses, once again, provides balance in an uncertain environment, giving us confidence in our ability to drive record earnings in fiscal 2025.&#8221;
FY25&nbsp;Outlook: Donaldson revised its guidance for adjusted EPS to $3.60 &#8211; $3.68 (vs. consensus of $3.63) from the <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">previous range of $3.56 &#8211; $3.72</a>.
The company now sees sales growth of flat to up 4%, compared to the earlier expectation of a 2% to 6% increase year-over-year.
Donaldson projects mobile sales growth to be&nbsp;down 1% to up 3%, Industrial sales growth of 1% to 5%, and Life Sciences sales to increase in the high single digits.
For the full year, Donaldson anticipates repurchasing approximately&nbsp;2%&nbsp;to&nbsp;3%&nbsp;of its shares outstanding.
Investors can gain exposure to the stock via&nbsp;VanEck Green Infrastructure ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNEW#NASDAQ">RNEW</a>) and VanEck Environmental Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVX#NYSE">EVX</a>).
Price Action: DCI shares are down 1.91% at $67.93 at the last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/44003404" target="_blank" rel="noreferrer noopener">Airbnb Is Nearly 40% More Expensive Than Its Rivals: Here&#8217;s What Key Indicators For ABNB Stock Reveal</a></li>
</ul>

Equities

Large Cap

Guidance

Dividends

Movers

Market Vectors Environmental Services Index Fund

RNEW

Donaldson Q2 Earnings Miss: Aftermarket And Life Sciences Segments Shine Amid Revenue Dip

Mobile sales are projected to be down 1% to up 3% versus 2024. Off-Road sales are expected to decline mid-single digits due to end-market weakness, particularly in agriculture. On-Road sales are forecast to decrease low-double digits due to an exit from non-strategic product sales combined with a decline in global truck production. Aftermarket sales are projected to increase low-single digits, driven by robust OEM channel demand and market share gains.
Industrial sales are forecast to grow between 1% and 5% year over year. IFS sales are projected to increase low-single digits with growth across most businesses, including dust collection, Industrial Hydraulics and Industrial Gases. Aerospace and Defense sales are expected to increase high-single digits as robust end-market conditions continue.
Life Sciences sales are forecast to grow high-single digits compared with 2024 driven by growth in Disk Drive and Food &amp; Beverage.
Adjusted operating margin, resulting from solid gross margin and operating expense leverage, is expected to be between 15.6% and 16.0%, up from previous guidance of 15.3% and 15.9%, and versus 15.2%, or 15.4% on an adjusted basis, in 2024.
Interest expense is estimated to be approximately $21 million and other income is forecast to be between $18 million and $20 million. Donaldson projects a fiscal 2025 effective income tax rate of between 23% and 25%.
Capital expenditures are forecast to be between $85 million and $100 million and free cash flow conversion is expected to be between 85% and 95%. For the full year, Donaldson anticipates repurchasing 2% to 3% of its shares outstanding.

Donaldson Revised Guidance For FY25 Adj. EPS To $3.60-$3.68 (From $3.56-$3.72 Earlier) Vs. Est. $3.63; Sales To Be Flat To Up 4% (From Increase 2%-6% YoY Earlier)

Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) reported quarterly earnings of $0.83 per share which missed the analyst consensus estimate of $0.85 by 2.35 percent. This is a 2.47 percent increase over earnings of $0.81 per share from the same period last year. The company reported quarterly sales of $870.00 million which missed the analyst consensus estimate of $908.33 million by 4.22 percent. This is a 0.76 percent decrease over sales of $876.70 million the same period last year.

Earnings Misses

Donaldson Q2 2025 Adj EPS $0.83 Misses $0.85 Estimate, Sales $870.00M Miss $908.33M Estimate

AAON

ABCL

ACEL

ACHC

ACHR

ACIC

ACIW

ADSK

AIRG

ALEX

ALHC

ALKT

ALTM

AMBP

AMPH

AMRC

AMWD

ARGX

ARLO

ARRY

ASTH

AUPH

AVPT

BBWI

BCSF

BECN

BLND

BWMX

CABO

CARS

CCOI

CDXS

CLCO

CLOV

CMBT

CMLS

CMPS

CODI

COLL

CRDF

CRNX

CRON

CSTL

CTKB

CUBE

CVEO

CYTK

DAIO

DCGO

DELL

DUOL

ECVT

EFXT

ERIE

Embraer-Empresa Brasileira De Aeronautica

ESEA

ESTC

EVRG

EXFY

FIGS

FOXF

FTDR

FWONA

FWONK

GBTG

GDEN

GDOT

GDRX

Earnings Scheduled For February 27, 2025

Donaldson's advanced air filter technology is set to be featured in the next-generation Freightliner SuperTruck III, further solidifying its position at the forefront of hydrogen fuel cell innovation.

Donaldson Enters Partnership With Daimler Truck North America On Hydrogen Fuel Cell Project

Morgan Stanley analyst Angel Castillo maintains Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) with a Underweight and raises the price target from $67 to $68.

Morgan Stanley Maintains Underweight on Donaldson, Raises Price Target to $68

Baird analyst Richard Eastman maintains Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) with a Outperform and raises the price target from $81 to $83.

Baird Maintains Outperform on Donaldson, Raises Price Target to $83

Donaldson shares are trading lower. The company reported Q1 financial results.

Donaldson Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) shares are trading lower after the company <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42284820/donaldson-reports-record-first-quarter-fiscal-2025-sales-and-earnings" rel="noreferrer noopener">reported&nbsp;first-quarter&nbsp;FY25 results</a>.
Sales increased&nbsp;6.4%&nbsp;year over year to&nbsp;$900.1 million,&nbsp;beating the consensus of&nbsp;$888.9 million, led by higher volume growth across all segments.
By Segment, Mobile Solutions sales surged&nbsp;6.0%, with Aftermarket sales climbing 10.7%, aided by market share gains and the impact of customer destocking in the prior-year period.
Industrial Solutions sales grew&nbsp;4.6%&nbsp;in the quarter, driven by a 26.8% surge in Aerospace and Defense sales on strong end-market conditions.
Life Sciences segment sales increased&nbsp;16.6%, led by market share gains, improved conditions in the Disk Drive market, and double-digit growth in Food &amp; Beverage sales.
Gross margin contracted 10 basis points to&nbsp;35.5%&nbsp;on higher costs. Adjusted EPS of&nbsp;83 cents&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus of&nbsp;82 cents</a>.
In the quarter, Donaldson paid&nbsp;$32.4&nbsp;million&nbsp;in dividends and repurchased shares worth&nbsp;$74.9&nbsp;million.
Last month, the Board of Directors declared a cash dividend per share of 27.0 cents, payable on December 23, to&nbsp;shareholders <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/b42146556/donaldson-company-declares-quarterly-cash-dividend" rel="noreferrer noopener">of record on December 9</a>.
Tod Carpenter, chairman, president, and chief executive officer, said, &#8220;We gained share in several of our key businesses while continuing the footprint and cost optimization initiatives we began last quarter, strengthening our foundation for higher profitability.&#8221;
FY25 Outlook: Donaldson reiterated EPS forecast at $3.56 &#8211; $3.72 (vs. consensus of $3.62) and sales growth guidance at 2% &#8211; 6%, with a <a href="https://www.benzinga.com/calendars/guidance">pricing benefit of around 1%.</a> 
Donaldson projects mobile sales growth to be&nbsp;flat to up 4%, Industrial sales growth between 4% and 8% and Life Sciences sales to increase in low-double digits.
For the full year, Donaldson anticipates repurchasing approximately 2% to 3% of its shares outstanding. The company expects capital expenditures of $85 million and $105 million in FY25.
Investors can gain exposure to the stock via&nbsp;ALPS O&#8217;Shares U.S. Small-Cap Quality Dividend ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/OUSM#BATS">OUSM</a>) and&nbsp;First Trust Horizon Managed Volatility Small/Mid ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HSMV#NYSE">HSMV</a>).
Price Action: DCI shares are down 4.56% at $74.51 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42255482/donaldson-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts" target="_blank" rel="noreferrer noopener">Donaldson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#8217;s Most Accurate Analysts</a></li>
</ul>

HSMV

O'Shares FTSE Russell Small Cap Quality Dividend ETF

OUSM

Donaldson Beats On Q1 Earnings On Strong Volumes, Reaffirms FY25 Guidance

Donaldson Reaffirmed Guidance For FY25 Adj. EPS At $3.56-$3.72 Vs. Est. $3.62; Sales Projected To Increase 2%-6% YoY

Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) reported quarterly earnings of $0.83 per share which beat the analyst consensus estimate of $0.82 by 1.22 percent. The company reported quarterly sales of $900.100 million which beat the analyst consensus estimate of $888.946 million by 1.25 percent. This is a 6.36 percent increase over sales of $846.300 million the same period last year.

Earnings Beats

Donaldson Q1 2025 Adj. EPS $0.83 Beats $0.82 Estimate, Sales $900.100M Beat $888.946M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Core &amp; Main (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNM#NYSE">CNM</a>) is likely to report quarterly earnings at $0.66 per share on revenue of $1.99 billion. 
• Citi Trends (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTRN#NASDAQ">CTRN</a>) is expected to report quarterly loss at $0.75 per share on revenue of $178.48 million. 
• REX American Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/REX#NYSE">REX</a>) is estimated to report quarterly earnings at $0.72 per share on revenue of $159.00 million. 
• Bank of Nova Scotia (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BNS#NYSE">BNS</a>) is likely to report quarterly earnings at $1.16 per share on revenue of $6.16 billion. 
• Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) is estimated to report quarterly earnings at $0.82 per share on revenue of $892.43 million. 
<h3>Companies Reporting After The Bell</h3>
• Descartes Systems Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DSGX#NASDAQ">DSGX</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $164.12 million. 
• Inotiv (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NOTV#NASDAQ">NOTV</a>) is estimated to report quarterly earnings at $0.00 per share on revenue of $116.94 million. 
• Torrid Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CURV#NYSE">CURV</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $284.29 million. 
• Pure Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $818.14 million. 
• Box (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $275.10 million. 
• Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) is expected to report quarterly earnings at $0.58 per share on revenue of $649.64 million. 
• Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) is estimated to report quarterly earnings at $0.41 per share on revenue of $1.46 billion. 
• Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) is projected to report quarterly loss at $0.08 per share on revenue of $50.77 million. 
• Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) is estimated to report quarterly earnings at $2.44 per share on revenue of $9.34 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BASE

CTRN

CURV

DSGX

MRVL

NOTV

OKTA

PSTG

Earnings Scheduled For December 3, 2024

Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) is gearing up to announce its quarterly earnings on Tuesday, 2024-12-03. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Donaldson will report an earnings per share (EPS) of $0.82.
Anticipation surrounds Donaldson's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Performance in Previous Earnings</h3>
In the previous earnings release, the company beat EPS by $0.06, leading to a 0.38% drop in the share price the following trading session.
Here's a look at Donaldson's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.88</td>
<td>0.83</td>
<td>0.74</td>
<td>0.72</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.94</td>
<td>0.92</td>
<td>0.81</td>
<td>0.75</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>2.0%</td>
<td>1.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1733148073_0.png" alt="eps graph" />
<h3>Donaldson Share Price Analysis</h3>
Shares of Donaldson were trading at $78.05 as of November 28. Over the last 52-week period, shares are up 27.97%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/DCI/earnings">To track all earnings releases for Donaldson visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: Donaldson's Quarterly Earnings

Donaldson Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) will release earnings results for the first quarter, before the <a href="https://www.benzinga.com/quote/DCI/earnings">opening bell on Tuesday, Dec. 3.</a>
Analysts expect Donaldson to report quarterly earnings at 82 cents per share. That's up from 75 cents per share a year ago. The Bloomington, Minnesota-based company projects to report quarterly revenue of $893.49 million, compared to $846.3 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Oct. 29, Donaldson Company said CFO Scott Robinson will retire on Oct. 31 and Brad Pogalz will assume the role.
Donaldson shares fell 0.5% to close at $77.64 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/DCI/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Stifel analyst Nathan Jones maintained a Hold rating and cut the price target from $76 to $71 on Aug. 29. This analyst has an accuracy rate of 82%.</li>
<li>Raymond James analyst Tim Thein initiated coverage on the stock with a Market Perform rating on June 28. This analyst has an accuracy rate of 81%.</li>
<li>Baird analyst Richard Eastman maintained an Outperform rating and cut the price target from $80 to $79 on June 3. This analyst has an accuracy rate of 80%.</li>
</ul>
Considering buying DCI stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="548" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28102549/image-308-1024x548.png" alt="" class="wp-image-669193" style="width:584px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28102549/image-308-1024x548.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28102549/image-308-300x161.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28102549/image-308-768x411.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/28102549/image-308.png 1152w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42221018/jim-cramer-reddit-is-fabulous-dow-is-a-tough-one">Jim Cramer: Reddit Is &#8216;Fabulous,&#8217; Dow Is A &#8216;Tough&#8217; One</a></li>
</ul>

Donaldson Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Press Releases

Donaldson Reports Record First Quarter Fiscal 2025 Sales and Earnings

Donaldson Company Declares Quarterly Cash Dividend

Donaldson Partners with Daimler Truck North America for Freightliner's SuperTruck III Project

Donaldson to Webcast Second Quarter Fiscal 2025 Earnings Conference Call

Donaldson Reports Second Quarter Fiscal Year 2025 Sales and Earnings

Donaldson Company to Present at the Raymond James 46th Annual Institutional Investors Conference

Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain

Donaldson Company Releases Fiscal Year 2024 Sustainability Report

Isolere Bio by Donaldson Passes Most Significant Milestone To-Date, Announces Availability of Manufacturing-Grade IsoTag™ AAV Reagent

Donaldson Company to Present at the Oppenheimer 20th Annual Industrial Growth Conference

Comments

Donaldson

뉴스

에 대한 최신 뉴스 Donaldson (NYSE:DCI) 주식

일요일, 12월 01, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌